PB2381: EFFICACY ANALYSIS OF BRUTON’S TYROSINE KINASE INHIBITOR COMBINED REGIMEN IN THE TREATMENT OF ELDERLY PATIENTS WITH RELAPSED/REFRACTORY PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA

Bibliographic Details
Main Author: Wenyu Shi
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000976240.96151.4d
_version_ 1797281554231197696
author Wenyu Shi
author_facet Wenyu Shi
author_sort Wenyu Shi
collection DOAJ
first_indexed 2024-03-07T16:59:11Z
format Article
id doaj.art-9c98dc9280d74169a3de7d2d13b67a3b
institution Directory Open Access Journal
issn 2572-9241
language English
last_indexed 2024-03-07T16:59:11Z
publishDate 2023-08-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj.art-9c98dc9280d74169a3de7d2d13b67a3b2024-03-03T03:25:49ZengWileyHemaSphere2572-92412023-08-017e961514d10.1097/01.HS9.0000976240.96151.4d202308003-02234PB2381: EFFICACY ANALYSIS OF BRUTON’S TYROSINE KINASE INHIBITOR COMBINED REGIMEN IN THE TREATMENT OF ELDERLY PATIENTS WITH RELAPSED/REFRACTORY PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMAWenyu Shi01 Affiliated Hospital of Nantong University, Department of Oncology, Nantong, Chinahttp://journals.lww.com/10.1097/01.HS9.0000976240.96151.4d
spellingShingle Wenyu Shi
PB2381: EFFICACY ANALYSIS OF BRUTON’S TYROSINE KINASE INHIBITOR COMBINED REGIMEN IN THE TREATMENT OF ELDERLY PATIENTS WITH RELAPSED/REFRACTORY PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
HemaSphere
title PB2381: EFFICACY ANALYSIS OF BRUTON’S TYROSINE KINASE INHIBITOR COMBINED REGIMEN IN THE TREATMENT OF ELDERLY PATIENTS WITH RELAPSED/REFRACTORY PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
title_full PB2381: EFFICACY ANALYSIS OF BRUTON’S TYROSINE KINASE INHIBITOR COMBINED REGIMEN IN THE TREATMENT OF ELDERLY PATIENTS WITH RELAPSED/REFRACTORY PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
title_fullStr PB2381: EFFICACY ANALYSIS OF BRUTON’S TYROSINE KINASE INHIBITOR COMBINED REGIMEN IN THE TREATMENT OF ELDERLY PATIENTS WITH RELAPSED/REFRACTORY PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
title_full_unstemmed PB2381: EFFICACY ANALYSIS OF BRUTON’S TYROSINE KINASE INHIBITOR COMBINED REGIMEN IN THE TREATMENT OF ELDERLY PATIENTS WITH RELAPSED/REFRACTORY PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
title_short PB2381: EFFICACY ANALYSIS OF BRUTON’S TYROSINE KINASE INHIBITOR COMBINED REGIMEN IN THE TREATMENT OF ELDERLY PATIENTS WITH RELAPSED/REFRACTORY PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
title_sort pb2381 efficacy analysis of bruton s tyrosine kinase inhibitor combined regimen in the treatment of elderly patients with relapsed refractory primary central nervous system lymphoma
url http://journals.lww.com/10.1097/01.HS9.0000976240.96151.4d
work_keys_str_mv AT wenyushi pb2381efficacyanalysisofbrutonstyrosinekinaseinhibitorcombinedregimeninthetreatmentofelderlypatientswithrelapsedrefractoryprimarycentralnervoussystemlymphoma